Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Recombinant human dyskerin

EU orphan designation number: EU/3/12/1070   
Active ingredient: Recombinant human dyskerin
Indication: Treatment of dyskeratosis congenita
Sponsor: Advanced Medical Projects
IIB-CSIC, C/ Arturo Duperier 4 , 28029 Madrid, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Orphan designation EMA/OD/136/11 (2012)8207 of 8/11/2012
20/12/2016 Change of name and/or address of sponsor